Connor, Clark & Lunn Investment Management (CC&L)’s Larimar Therapeutics LRMR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-23,521
| Closed | -$154K | – | 1531 |
|
|
2024
Q3 | $154K | Sell |
23,521
-311
| -1% | -$2.04K | ﹤0.01% | 1347 |
|
|
2024
Q2 | $173K | Sell |
23,832
-34,284
| -59% | -$249K | ﹤0.01% | 1275 |
|
|
2024
Q1 | $441K | Buy |
+58,116
| New | +$441K | ﹤0.01% | 1149 |
|
|
2023
Q4 | – | Sell |
-21,835
| Closed | -$86.2K | – | 1486 |
|
|
2023
Q3 | $86.2K | Sell |
21,835
-26,239
| -55% | -$104K | ﹤0.01% | 1303 |
|
|
2023
Q2 | $150K | Buy |
48,074
+6,227
| +15% | +$19.5K | ﹤0.01% | 1222 |
|
|
2023
Q1 | $190K | Buy |
41,847
+4,362
| +12% | +$19.8K | ﹤0.01% | 1105 |
|
|
2022
Q4 | $155K | Buy |
37,485
+24,420
| +187% | +$101K | ﹤0.01% | 1082 |
|
|
2022
Q3 | $42K | Buy |
+13,065
| New | +$42K | ﹤0.01% | 1069 |
|
|
2019
Q3 | – | Sell |
-118,668
| Closed | -$141K | – | 1031 |
|
|
2019
Q2 | $141K | Sell |
118,668
-131,423
| -53% | -$156K | ﹤0.01% | 934 |
|
|
2019
Q1 | $685K | Buy |
250,091
+3,550
| +1% | +$9.73K | ﹤0.01% | 608 |
|
|
2018
Q4 | $1.22M | Buy |
246,541
+16,622
| +7% | +$82.2K | 0.01% | 511 |
|
|
2018
Q3 | $2.69M | Buy |
229,919
+37,899
| +20% | +$443K | 0.02% | 397 |
|
|
2018
Q2 | $1.96M | Buy |
192,020
+14,790
| +8% | +$151K | 0.01% | 480 |
|
|
2018
Q1 | $1.32M | Buy |
177,230
+11,505
| +7% | +$85.7K | 0.01% | 448 |
|
|
2017
Q4 | $766K | Hold |
165,725
| – | – | ﹤0.01% | 558 |
|
|
2017
Q3 | $583K | Hold |
165,725
| – | – | ﹤0.01% | 615 |
|
|
2017
Q2 | $582K | Buy |
165,725
+25,100
| +18% | +$88.1K | ﹤0.01% | 577 |
|
|
2017
Q1 | $655K | Buy |
140,625
+26,925
| +24% | +$125K | ﹤0.01% | 578 |
|
|
2016
Q4 | $362K | Buy |
113,700
+12,375
| +12% | +$39.4K | ﹤0.01% | 677 |
|
|
2016
Q3 | $335K | Buy |
101,325
+23,900
| +31% | +$79K | ﹤0.01% | 651 |
|
|
2016
Q2 | $464K | Buy |
77,425
+17,300
| +29% | +$104K | ﹤0.01% | 594 |
|
|
2016
Q1 | $402K | Buy |
60,125
+7,300
| +14% | +$48.8K | ﹤0.01% | 601 |
|
|
2015
Q4 | $332K | Buy |
52,825
+42,125
| +394% | +$265K | ﹤0.01% | 610 |
|
|
2015
Q3 | $342K | Buy |
+10,700
| New | +$342K | ﹤0.01% | 579 |
|